FIELD: medicine.
SUBSTANCE: invention describes application of compound which has formula or its salt for prevention or reduction of biofilm formation on abiotic surface or for prevention or reduction of viable microbes growth on abiotic surface, where R1 represents straight or branched alkyl group containing from 8 to 16 carbon atoms in the 2-nd or 3-d position of morpholene ring and R2 represents straight or branched alkyl group containing from 2 to 10 carbon atoms substituted with hydroxy group, except in alfa-position, sum of carbon atoms in groups R1 and R2 constituting at least 10 and preferably 20. Abiotic surface is a medical device, device for fluid medium storage, device of fluid storage delivery or surgical instrument.
EFFECT: invention ensures non-viability of any bacterial biofilm.
20 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MODIFIED SURFACE WITH ABILITY TO ACQUIRE BACTERIOSTATIC AND BACTERICIDE ACTIVITY AND METHOD OF ITS PRODUCTION AND APPLICATIONS | 2014 |
|
RU2650376C2 |
MEDICAL DEVICE WITH SURFACE CONTAINING ANTIMICROBIAL METAL | 2013 |
|
RU2651463C1 |
ANTIMICROBIAL COMPOSITIONS | 2013 |
|
RU2694758C2 |
MEDICAL DEVICE WITH SURFACE CONTAINING GALLOUS OXIDE | 2013 |
|
RU2636515C1 |
INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
MEDICAL IMPLANTS WITH HIGHER HYDROPHILITY | 2011 |
|
RU2643915C2 |
MATERIALS AND METHODS FOR CONTROLLING INFECTIONS | 2014 |
|
RU2682642C1 |
MEDICAL DEVICE CONTAINING COLLAGEN VI | 2014 |
|
RU2693408C2 |
APPLICATION OF NITROCARBOXYLIC ACIDS FOR TREATMENT, DIAGNOSTICS AND PREVENTION OF AGGRESSIVE FORMS OF HEALING | 2011 |
|
RU2567049C2 |
OSTEOSYNTHESIS WITH NANOSILVER | 2010 |
|
RU2557938C2 |
Authors
Dates
2009-12-10—Published
2006-02-01—Filed